Validity of the fractional exhaled nitric oxide (FENO ) for identification of bronchial hyperresponsiveness in a pulmonary function laboratory Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013
Exhaled breath histamine is reduced following methacholine challenge in patients with mild asthma Source: Eur Respir J 2001; 18: Suppl. 33, 165s Year: 2001
Noninvasive assessment of airway inflammation in asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=164 Year: 2003
Diagnosing asthma and prognostic significance of eNO Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management Year: 2005
Airway hyperresponsiveness, but not exhaled nitric oxide, as a risk factor for decline in post-bronchodilator FEV1 in patients with stable asthma Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis Year: 2008
Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013
Assessment of diagnostic accuracy of lung function indices and FeNO for a positive methacholine challenge in suspected asthmatics Source: International Congress 2018 – Asthma management Year: 2018
Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine Source: Annual Congress 2013 –New issues in lung function testing Year: 2013
Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma Source: Eur Respir J 2002; 20: 1393-1398 Year: 2002
Association of childhood asthma and smoking with FEV1, bronchial reactivity and exhaled nitric oxide in young men with current symptomatic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 681s Year: 2004
Characterization of airway inflammation in patients with asthma COPD overlap syndrome using FeNO levels Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015
Screening with exhaled nitric oxide (ENO) may identify cases with on-going bronchial inflammation but not asthma symptoms Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001
Determine the relationship between fraction exhaled nitric oxide (FeNO) and mannitol challenge test in the diagnosis of suspected asthma patients. Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics Year: 2020
Clinically relevant early functional and diagnostic markers of lung disease in children Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120 Year: 2006
Effects of roflumilast on exhaled NO, airway hyperresponsiveness, and inflammatory markers in patients with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006
Exhaled nitric oxide as predictor of bronchial hyperresponsiveness to methacholine in subjects with respiratory symptoms Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
Diagnostic value of induced sputum and nitric oxide in exhaled breath condensate to control treatment of bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 503s Year: 2006
Correlation between exhaled nitric oxide, airway hyper responsiveness and pulmonary function data in patients with suspected asthma Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Usefulness of fractional exhaled nitric oxide (FeNO) for early diagnosis of asthma in patients with nonspecific respiratory symptoms Source: Annual Congress 2009 - From cough to sound analysis of breathing Year: 2009
The influence of asthma and COPD exacerbation on exhaled mitric oxide (FENO ) Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004